Messenger Biopharma will not develop its own mRNA products and will not produce mRNA.

We are eager to out-license our technologies to pharmaceutical companies for the development of mRNA vaccines and therapies, and to CDMOs for the production of mRNA using at least one of our technologies.

Last news


Messenger Biopharma in Lyonbiopole’s newsletter

posted December 22, 2016

  Please click on this ...Read More